EF
WST icon

Empirical Finance’s West Pharmaceutical WST Stock Holding History

Empirical Finance’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$898K Buy
2,501
+85
+4% +$26K 0.04% 328
2026
Q1 		$606K Sell
2,416
-3
-0.1% -$746 0.03% 386
2025
Q4 		$666K Sell
2,419
-102
-4% -$27.9K 0.03% 364
2025
Q3 		$661K Buy
2,521
+24
+1% +$5.83K 0.03% 386
2025
Q2 		$546K Buy
2,497
+21
+0.8% +$4.49K 0.03% 410
2025
Q1 		$554K Buy
2,476
+80
+3% +$22K 0.03% 389
2024
Q4 		$785K Sell
2,396
-20
-0.8% -$6.29K 0.05% 317
2024
Q3 		$725K Buy
2,416
+57
+2% +$17.5K 0.04% 339
2024
Q2 		$777K Sell
2,359
-147
-6% -$52K 0.05% 313
2024
Q1 		$992K Buy
2,506
+89
+4% +$32.9K 0.06% 277
2023
Q4 		$851K Buy
2,417
+23
+1% +$8.14K 0.06% 288
2023
Q3 		$898K Buy
2,394
+236
+11% +$91.3K 0.07% 257
2023
Q2 		$825K Buy
2,158
+279
+15% +$99.7K 0.06% 270
2023
Q1 		$651K Buy
1,879
+85
+5% +$24.8K 0.06% 297
2022
Q4 		$422K Buy
1,794
+157
+10% +$37.2K 0.04% 370
2022
Q3 		$403K Buy
1,637
+298
+22% +$90.8K 0.05% 332
2022
Q2 		$405K Buy
1,339
+75
+6% +$24.4K 0.05% 323
2022
Q1 		$519K Buy
1,264
+153
+14% +$59.9K 0.06% 300
2021
Q4 		$521K Buy
1,111
+358
+48% +$154K 0.06% 287
2021
Q3 		$320K Buy
753
+59
+9% +$24.9K 0.05% 335
2021
Q2 		$249K Buy
+694
New +$229K 0.04% 362

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Empirical Finance's WST Position: Q2 2026 in Review

Empirical Finance increased its West Pharmaceutical (WST) stake by 3.5% in Q2 2026, buying an estimated $26K and bringing the position to 2,501 shares worth $898K. The position accounts for 0.04% of the portfolio, ranked #328.

Empirical Finance first reported a position in WST in Q2 2021 and has held it in 21 quarters since. The position peaked at $992K in Q1 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Empirical Finance held 2,501 shares of West Pharmaceutical worth $898K as of Q2 2026.
  • Empirical Finance bought 85 West Pharmaceutical shares in Q2 2026, an estimated $26K.
  • West Pharmaceutical made up 0.04% of Empirical Finance's portfolio in Q2 2026, its #328 holding.
  • Empirical Finance first reported a position in West Pharmaceutical in Q2 2021 and has held it in 21 quarters since.
  • Empirical Finance's West Pharmaceutical position peaked at $992K in Q1 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.